AstraZeneca Tries To Halt Apotex Pulmicort Launch
AstraZeneca Pharmaceuticals LP has asked a federal court to stop Canadian drugmaker Apotex Inc. from launching a generic version of children's asthma medication Pulmicort Respules, one week after the U.S. Food...To view the full article, register now.
Already a subscriber? Click here to view full article